Mr. George Robinson reports
RAVENQUEST FIRMS UP PLAN TO STRENGTHEN BALANCE SHEET, SETTLE
DEBENTURES, AND SOLVING OUTSTANDING DISPUTES
Ravenquest Biomed Inc. is providing the
following update on its business plans.
Ravenquest is endeavouring to raise money while negotiations on the convertible debentures have stalled.
Negotiations on the company's two leases for Markham and Edmonton have not yet been finalized. At this point, Ravenquest has limited access to both of its facilities. It will continue to negotiate on its leases in good faith with
its landlords.
About Ravenquest Biomed Inc.
Ravenquest is a diversified publicly traded cannabis company with divisions focused on
cannabis production, management services and consulting, and specialized research and development.
We seek Safe Harbor.
© 2026 Canjex Publishing Ltd. All rights reserved.